Our understanding of how preeclampsia develops and changes across pregnancy has grown, including the contributions of inflammation, oxidative stress, and blood vessel health. Yet, our ability to prevent and predict preeclampsia has made much less progress. Authors of this paper suggest that one reason for this may be that not all cases or outcomes of preeclampsia are the same and that preeclampsia is not just one disorder. There is increasing attention now on possible subtypes for preeclampsia, recognizing that 1) preeclampsia has different presentations and outcomes 2) there is a wide range in risk factors for preeclampsia, and 3) fetal effects like growth restriction/low birthweight are not present in all cases. For the field of preeclampsia to move forward, work should be done to define clear and useful subtypes with the following criteria: 1) each preeclampsia subtype should develop during pregnancy in a particular way, perhaps with maternal symptoms appearing in a predictable order when there is a risk factor, or should result in a specific maternal or fetal outcome (like delivery before 34 weeks), 2) each preeclampsia subtype should be something care providers and women can use for decision-making about care, so it shouldn’t be time-consuming to diagnose, and 3) the results should be reproducible, which means that these subtypes appear over and over in different pregnancies by different women. This is important so that different subtypes can be targeted with specific treatments (that is, providers could use more of a ‘precision medicine’ approach to individual pregnancies).
LINK: https://pubmed.ncbi.nlm.nih.gov/33775113/
Each quarter, our team of researchers reviews the most current studies related to hypertensive disorders of pregnancy and selects those studies they feel will be of greatest interest to our community to summarize.
Special thanks to our volunteer research team, who under the leadership of Dr. Elizabeth Sutton, make Research Roundup possible: Alisse Hauspurg, MD Felicia LeMoine, MD Jenny Sones, PhD, DVM, and Robin Trupp, PhD, RN.
Your story is needed to improve outcomes for moms like you. Add your voice to critical preeclampsia research to ensure that every story is heard.
Frequently asked questions about the Preeclampsia Registry, a patient-driven registry and biobank.
The Preeclampsia Foundation offers research funding, study recruitment, and other patient engagement services to researchers.
We provide research grant funding to advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy.
Preeclampsia is a serious complication of pregnancy that can affect a woman’s health beyond pregnancy. For a long time, it has been clear that women who experience preeclampsia have a greater ch...
Black women in the United States experience preeclampsia more often and are more likely to experience severe complications from it than White women. Traditional risk factors, such as high blood pressu...
High blood pressure disorders during pregnancy, including preeclampsia and gestational hypertension, are common complications that affect approximately 5–10% of pregnancies. Although these condi...
Preeclampsia is a serious pregnancy complication that causes high blood pressure and can harm organs like the kidneys, liver, and brain. It affects thousands of pregnancies every year and remains one...
Hypertensive disorders of pregnancy, such as high blood pressure during pregnancy, are a major cause of illness and death for mothers. It is important to find women who are at risk as early as possibl...
